Michael Luebbert
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 23
- Acute Myeloid Leukemia Research 21
- Chronic Myeloid Leukemia Treatments 4
- Genetics 11
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Co-authors
- Hans Michael Kvasnicka (1 shared paper)Annette Hildegard Schmitt-Graeff (1 shared paper)J. Thiele (1 shared paper)J. W. Vardiman (1 shared paper)Volker Diehl (1 shared paper)Ulrich Germing (1 shared paper)Norbert Gattermann (1 shared paper)Peter Valent (3 shared papers)
- Journals
- Blood (24 papers)Leukemia Research (2 papers)Leukemia (1 paper)BMC Cancer (1 paper)Annals of Hematology (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael Luebbert
29 papers receiving 2.9k citations
Michael Luebbert's Hit Papers
Peers
Comparison fields: 5 of 65
- Hematology 2.6k
- Genetics 1.0k
- Emergency Medicine 253
- Orthopedics and Sports Medicine 125
- Pathology and Forensic Medicine 227
Countries citing papers authored by Michael Luebbert
This map shows the geographic impact of Michael Luebbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Luebbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Luebbert more than expected).
Fields of papers citing papers by Michael Luebbert
This network shows the impact of papers produced by Michael Luebbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Luebbert. The network helps show where Michael Luebbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Luebbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes Hit paper breakdown → | 2012 | 2463 |
| 2 | 2016 | 151 | |
| 3 | 2015 | 105 | |
| 4 | 2016 | 48 | |
| 5 | 2020 | 25 | |
| 6 | 2011 | 23 | |
| 7 | 2004 | 18 | |
| 8 | 2022 | 14 | |
| 9 | 2006 | 8 | |
| 10 | 2006 | 7 | |
| 11 | 2009 | 7 | |
| 12 | DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine). | 1999 | 5 |
| 13 | 2009 | 5 | |
| 14 | 2015 | 3 | |
| 15 | 2013 | 3 | |
| 16 | 2015 | 3 | |
| 17 | 2008 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2005 | 2 | |
| 20 | 2013 | 2 |
About Michael Luebbert
Michael Luebbert is a scholar working on Hematology, Genetics, Emergency Medicine, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 31 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hematological disorders and diagnostics (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.0k citations), Emergency Medicine (253 citations), Orthopedics and Sports Medicine (125 citations) and Pathology and Forensic Medicine (227 citations). Michael Luebbert has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Hans Michael Kvasnicka, Annette Hildegard Schmitt-Graeff, J. Thiele, J. W. Vardiman, Volker Diehl, Ulrich Germing, Norbert Gattermann, Peter Valent, Otto Krieger and Barbara Hildebrandt. Their work appears in journals such as Blood, Leukemia Research, Leukemia, BMC Cancer and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.